Pharmaceutical giant, Eli Lilly and Company, plead guilty to promoting its drug Zyprexa for “off-label” uses. The plea resulted in the company paying $515 million in criminal fines. This is the largest payment made from an individual corporate criminal fine in history. In addition to the large payout, Eli Lilly signed a civil settlement admitting that by marketing the drug for unapproved use, it caused false claims for payment and negatively affected insurance programs like Medicaid. The civil settlement also includes an $800 million payout to resolve the original qui tam lawsuits brought against the company.

Although the drug was approved to treat manifestations of psychotic disorders, Eli Lilly taught their sales force to convince doctors to use the drug for treating dementia, Alzheimer’s dementia, depression and others disorders.

Click here to read the full news release by the DoJ on Eli Lilly and the agreement to pay $1.415 billion